ADMA Biologics, Inc. (ADMA)
20.11
+0.39
(+1.98%)
USD |
NASDAQ |
Dec 04, 16:00
20.16
+0.05
(+0.25%)
After-Hours: 20:00
ADMA Biologics Market Cap: 4.786B for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.492B |
| Vanda Pharmaceuticals, Inc. | 307.30M |
| Aldeyra Therapeutics, Inc. | 293.59M |
| Exelixis, Inc. | 11.90B |
| Arcutis Biotherapeutics, Inc. | 3.817B |
Market Cap Related Metrics
| PE Ratio | 23.62 |
| PS Ratio | 10.12 |
| PEG Ratio | 0.1134 |
| Price to Book Value | 11.10 |
| Price to Free Cash Flow | 121.81 |
| Price | 20.11 |
| Earnings Yield | 4.23% |
| PEGY Ratio | 0.1134 |
| Operating PE Ratio | 29.62 |
| Normalized PE Ratio | 23.26 |